Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serotonergic function during lithium augmentation of refractory depression.

E McCance-Katz1, L H Price, D S Charney

  • 1Clinical Neuroscience Research Unit, Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven.

Psychopharmacology
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome.

Translational psychiatry·2017
Same author

The MCP-4/MCP-1 ratio in plasma is a candidate circadian biomarker for chronic post-traumatic stress disorder.

Translational psychiatry·2017
Same author

Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial.

Psychological medicine·2015
Same author

Serotonin versus catecholamine deficiency: behavioral and neural effects of experimental depletion in remitted depression.

Translational psychiatry·2015
Same author

Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder.

Translational psychiatry·2015
Same author

Developing cognitive-emotional training exercises as interventions for mood and anxiety disorders.

European psychiatry : the journal of the Association of European Psychiatrists·2014
Same journal

Effects of repeated treatment with opioids that vary in mu opioid receptor efficacy on pain-depressed locomotor behavior in mice.

Psychopharmacology·2026
Same journal

Cannabidiol in the anterior insular cortex attenuates chronic neuropathic pain and comorbid anxiety- and depression-like behaviors: involvement of CB<sub>1</sub> and 5-HT<sub>1A</sub> receptor signaling.

Psychopharmacology·2026
Same journal

Fentanyl decreases arterial blood oxygen saturation more than furanylfentanyl in mice due to increased apnea.

Psychopharmacology·2026
Same journal

Suicide attempt risk among patients receiving methylphenidate: a retrospective cohort study.

Psychopharmacology·2026
Same journal

Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.

Psychopharmacology·2026
Same journal

OPRD1 rs4654327 and Outcomes of Extended-Release Naltrexone in Alcohol Use Disorder: An Exploratory Prospective Pharmacogenetic Study.

Psychopharmacology·2026
See all related articles

Lithium augmentation significantly increased the prolactin response in patients with major depression, suggesting a role for serotonin in its mechanism. This finding supports the use of lithium in treatment-resistant depression.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Serotonergic pathways are crucial in depression pathophysiology and antidepressant action.
  • The prolactin (PRL) response to L-tryptophan (L-TRP) serves as a measure of central serotonergic function.

Purpose of the Study:

  • To investigate the role of serotonin in lithium augmentation for major depression using the L-TRP test.
  • To assess changes in serotonergic activity following lithium augmentation in treatment-resistant depression.

Main Methods:

  • Twenty-six patients with antidepressant-refractory major depression underwent three L-TRP tests.
  • Tests were conducted after placebo, primary antidepressant treatment, and lithium augmentation.
  • Prolactin response was measured as an indicator of serotonergic function.

Related Experiment Videos

Main Results:

  • Primary antidepressant treatment did not significantly alter the PRL response.
  • Lithium augmentation led to a statistically significant increase in PRL response compared to placebo (P < 0.04).
  • Lithium augmentation also significantly increased PRL response compared to antidepressant treatment alone (P < 0.025).

Conclusions:

  • Lithium augmentation enhances central serotonergic activity in patients with major depression.
  • These findings support a role for serotonergic mechanisms in the therapeutic effects of lithium augmentation.
  • The L-TRP test is a valuable tool for assessing serotonergic function in psychiatric research.